Home LiteratureArticle Details
PMID: 14557637 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes.

Journal of virology ·Vol. 77 ·No. 21 ·2003-11-00 ·Pages 11517-30

Midgley RS, Bell AI, McGeoch DJ, Rickinson AB

Abstract

Epstein-Barr virus (EBV) strains from the highly HLA-A11-positive Chinese population are predominantly type 1 and show a variety of sequence changes (relative to the contemporary Caucasian prototype strain B95.8) in the nuclear antigen EBNA3B sequences encoding two immunodominant HLA-A11 epitopes, here called IVT and AVF. This has been interpreted by some as evidence of immune selection and by others as random genetic drift. To study epitope variation in a broader genomic context, we sequenced the whole of EBNA3B and parts of the EBNA2, 3A, and 3C genes from each of 31 Chinese EBV isolates. At each locus, type 1 viruses showed <2% nucleotide divergence from the B95.8 prototype while type 2 sequences remained even closer to the contemporary African prototype Ag876. However, type 1 isolates could clearly be divided into families based on linked patterns of sequence divergence from B95.8 across all four EBNA loci. Different patterns of IVT and AVF variation were associated with the different type 1 families, and there was additional epitope diversity within families. When the EBNA3 gene sequences of type 1 Chinese strains were subject to computer-based analysis, particular codons within the A11-epitope-coding region were among the few identified as being under positive or diversifying selection pressure. From these results, and the observation that mutant epitopes are consistently nonimmunogenic in vivo, we conclude that the immune selection hypothesis remains viable and worthy of further investigation.

MeSH Terms
Amino Acid Sequence China Computational Biology Conserved Sequence Epitopes, T-Lymphocyte/genetics Epstein-Barr Virus Nuclear Antigens/chemistry,genetics Genetic Variation HLA-A Antigens/metabolism HLA-A11 Antigen Herpesvirus 4, Human/classification,genetics,physiology Humans Polymorphism, Genetic Selection, Genetic Sequence Analysis, DNA T-Lymphocytes, Cytotoxic Virus Latency/genetics
Chemicals
EBNA-3B antigen Epitopes, T-Lymphocyte Epstein-Barr Virus Nuclear Antigens HLA-A Antigens HLA-A11 Antigen
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Midgley R S
CRUK Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TT, United Kingdom.
Bell A I
McGeoch D J
Rickinson A B
References (35)
35 references, click to expand
  1. Codon-substitution models for heterogeneous selection pressure at amino acid sites.
    Genetics. 2000 May;155(1):431-49 PMID: 10790415
  2. Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift.
    J Virol. 1997 Nov;71(11):8340-6 PMID: 9343187
  3. The immunology of Epstein-Barr virus infection.
    Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):475-88 PMID: 11313006
  4. HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences.
    J Virol. 2003 Nov;77(21):11507-16 PMID: 14557636
  5. A codon-based model of nucleotide substitution for protein-coding DNA sequences.
    Mol Biol Evol. 1994 Sep;11(5):725-36 PMID: 7968486
  6. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene.
    Genetics. 1998 Mar;148(3):929-36 PMID: 9539414
  7. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.
    J Virol. 1993 Mar;67(3):1572-8 PMID: 7679748
  8. Statistical methods for detecting molecular adaptation.
    Trends Ecol Evol. 2000 Dec 1;15(12):496-503 PMID: 11114436
  9. EBV strain variation: geographical distribution and relation to disease state.
    Virology. 1992 Sep;190(1):168-75 PMID: 1356286
  10. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.
    J Virol. 1990 Sep;64(9):4084-92 PMID: 2166806
  11. Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexes.
    J Immunol. 1997 Dec 1;159(11):5383-90 PMID: 9548478
  12. Novel intertypic recombinants of epstein-barr virus in the chinese population.
    J Virol. 2000 Feb;74(3):1544-8 PMID: 10627567
  13. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.
    Int J Cancer. 1998 May 4;76(3):399-406 PMID: 9579578
  14. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
    Proc Natl Acad Sci U S A. 1984 Dec;81(23):7632-6 PMID: 6209719
  15. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.
    Annu Rev Immunol. 1999;17:51-88 PMID: 10358753
  16. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.
    Nature. 1995 Jun 22;375(6533):685-8 PMID: 7540727
  17. Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells.
    J Gen Virol. 1997 Jul;78 ( Pt 7):1663-70 PMID: 9225043
  18. Codon-substitution models for detecting molecular adaptation at individual sites along specific lineages.
    Mol Biol Evol. 2002 Jun;19(6):908-17 PMID: 12032247
  19. Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals.
    J Virol. 1996 Aug;70(8):4895-903 PMID: 8763992
  20. Toward a comprehensive phylogeny for mammalian and avian herpesviruses.
    J Virol. 2000 Nov;74(22):10401-6 PMID: 11044084
  21. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population.
    Science. 1993 Apr 2;260(5104):98-100 PMID: 7682013
  22. Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China.
    Int J Cancer. 1998 Apr 13;76(2):207-15 PMID: 9537582
  23. A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis.
    Nat Med. 1998 Aug;4(8):939-44 PMID: 9701247
  24. A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa.
    J Virol. 1996 Jul;70(7):4228-36 PMID: 8676443
  25. Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution.
    J Virol. 1996 Apr;70(4):2490-6 PMID: 8642677
  26. Likelihood ratio tests for detecting positive selection and application to primate lysozyme evolution.
    Mol Biol Evol. 1998 May;15(5):568-73 PMID: 9580986
  27. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.
    J Exp Med. 1994 Apr 1;179(4):1297-305 PMID: 7511684
  28. Sequence variation in the Epstein-Barr virus latent membrane protein 1.
    J Gen Virol. 1994 Oct;75 ( Pt 10):2729-40 PMID: 7931159
  29. EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes.
    J Virol. 1996 Jun;70(6):4179-83 PMID: 8648764
  30. Detection and prevalence of the "f" variant of Epstein-Barr virus in southern China.
    Virology. 1991 Nov;185(1):67-71 PMID: 1656606
  31. Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population.
    Eur J Immunol. 1995 Jan;25(1):102-10 PMID: 7531142
  32. Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory.
    J Exp Med. 1996 Nov 1;184(5):1801-13 PMID: 8920868
  33. Synonymous and nonsynonymous rate variation in nuclear genes of mammals.
    J Mol Evol. 1998 Apr;46(4):409-18 PMID: 9541535
  34. Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD).
    Springer Semin Immunopathol. 1998;20(3-4):325-42 PMID: 9870249
  35. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules.
    Annu Rev Immunol. 2002;20:463-93 PMID: 11861610
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2003-11-00
Pages
11517-30
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC229270
Subset
IM
Grants
Wellcome Trust · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com